CCL22 is produced by tumor-associated macrophages (TAM) and DC in CRC and PDAC [70], cervical carcinoma [25], HNSCC [66,72] and ovarian carcinoma [22]. This evidence concerns the gene CCL22 and head and neck squamous cell carcinoma.